-
公开(公告)号:KR1020110021016A
公开(公告)日:2011-03-04
申请号:KR1020090078547
申请日:2009-08-25
Applicant: 가톨릭대학교 산학협력단 , 한림제약(주)
IPC: A61K31/4704 , A61P19/02 , A61K9/20 , A61K9/48
CPC classification number: A61K31/4704
Abstract: PURPOSE: A pharmaceutical composition containing rabamipide and pharmaceutically acceptable carrier is provided to prevent or treat rheumatoid arthritis. CONSTITUTION: A pharmaceutical composition for preventing or treating rheumatoid arthritis contains rabamipid and pharmaceutically acceptable carrier. The pharmaceutical composition is used for oral administration. The pharmaceutical composition is formed in oral solid dosage. The pharmaceutical composition has rabamipid formulated in 0.5-50 mg/kg of unit dosage form.
Abstract translation: 目的:提供含有拉巴米特和药学上可接受的载体的药物组合物,以预防或治疗类风湿性关节炎。 构成:用于预防或治疗类风湿性关节炎的药物组合物含有拉帕米特和药学上可接受的载体。 药物组合物用于口服给药。 药物组合物以口服固体剂量形成。 药物组合物具有配制在0.5-50mg / kg单位剂型中的拉巴米特。
-
公开(公告)号:KR1020100060673A
公开(公告)日:2010-06-07
申请号:KR1020080119366
申请日:2008-11-28
Applicant: 한림제약(주)
CPC classification number: A61K36/87 , A61K9/0048
Abstract: PURPOSE: A pharmaceutical composition of eye drop liquids and solutions or gels containing Vitis vinifera seed extract and antioxidant is provided to maintain physical and chemical stability. CONSTITUTION: A pharmaceutical composition of eye drop liquids and solutions or gels contains 0.1-30 weight% of Vitis vinifera seed extract, ascorbic acid or salt thereof, sodium bisulfate, potassium metabisulphite, or L-threonine, or antioxidant of salt thereof. The Vitis vinifera seed extract contains 80-130 of procyanidolic value(PCV); 30% or less (+)catechin and (-) epicatechin; and 95-105% of proanthocyanidine.
Abstract translation: 目的:提供含有葡萄种子提取物和抗氧化剂的滴眼液和溶液或凝胶的药物组合物,以维持物理和化学稳定性。 构成:滴眼液和溶液或凝胶的药物组合物含有0.1-30重量%的葡萄籽种子提取物,抗坏血酸或其盐,硫酸氢钠,偏亚硫酸氢钾或L-苏氨酸或其盐的抗氧化剂。 葡萄籽提取物含有原花青素含量(PCV)80-130; 30%以下(+)儿茶素和( - )表儿茶素; 和95-105%的原花青素。
-